Fri, October 13, 2017
Thu, October 12, 2017
Wed, October 11, 2017
Tue, October 10, 2017
Mon, October 9, 2017
Fri, October 6, 2017
Thu, October 5, 2017
Wed, October 4, 2017
Tue, October 3, 2017
Mon, October 2, 2017
Fri, September 29, 2017
Thu, September 28, 2017
Wed, September 27, 2017
Tue, September 26, 2017
Mon, September 25, 2017
Fri, September 22, 2017

Matthew Harrison Upgraded (BIIB) to Buy on, Oct 5th, 2017


//stocks-investing.news-articles.net/content/201 .. rrison-upgraded-biib-to-buy-on-oct-5th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Matthew Harrison of Morgan Stanley, Upgraded "Biogen Inc." (BIIB) to Buy on, Oct 5th, 2017.

Matthew has made no other calls on BIIB in the last 4 months.



There are 8 other peers that have a rating on BIIB. Out of the 8 peers that are also analyzing BIIB, 5 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Christopher Raymond of "Raymond James" Downgraded from Strong Buy to Hold on, Thursday, September 21st, 2017
  • Brian Abrahams of "RBC Capital" Initiated at Hold and Held Target at $319 on, Friday, September 15th, 2017
  • Jeffrey Silber of "BMO Capital" Maintained at Hold with Increased Target to $377 on, Wednesday, September 13th, 2017
  • Carter Gould of "UBS" Maintained at Hold with Increased Target to $285 on, Wednesday, July 26th, 2017
  • Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017


These are the ratings of the 3 analyists that currently disagree with Matthew


  • Robyn Karnauskas of "SunTrust Robinson Humphrey" Initiated at Strong Buy and Held Target at $360 on, Wednesday, September 20th, 2017
  • Terence Flynn of "Goldman Sachs" Upgraded at Strong Buy on, Wednesday, August 16th, 2017
  • Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017

Publication Contributing Sources